Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles

(2017) Gijung Kwak et al.   JOURNAL OF CONTROLLED RELEASE

Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients

(2017) Pierpaolo Pastina et al.   Journal of Thoracic Disease

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

(2015) Andrea Camerini et al.   BMC CANCER

Oxymatrine suppresses proliferation and induces apoptosis of hemangioma cells through inhibition of HIF-1a signaling

(2015) Z-W Fei et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Circulating Endothelial Cells and Circulating Progenitor Cells in Breast Cancer: Relationship to Endothelial Damage/Dysfunction/ Apoptosis, Clinicopathologic Factors, and the Nottingham Prognostic Index

(2015) Patrick K.Y. Goon et al.   NEOPLASIA

Angiogenic T cells are decreased in rheumatoid arthritis patients

(2014) Javier Rodríguez-Carrio et al.   ANNALS OF THE RHEUMATIC DISEASES

Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth

(2014) Kshitij Srivastava et al.   CANCER CELL

Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma

(2014) JUAN FAN et al.   Oncology Letters

Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells

(2012) Burcak Karaca et al.   MOLECULAR BIOLOGY REPORTS

Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice

(2012) Xingqun Ma et al.   PLoS One

Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients

(2012) J. Rodriguez-Carrio et al.   RHEUMATOLOGY

Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer

(2011) Zheng-tao Zhou et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications

(2011) Aspasia Soultati et al.   CANCER TREATMENT REVIEWS

Sulfosalicylate mediates improved vinorelbine loading into LUVs and antineoplastic effects

(2011) ChunLei Li et al.   JOURNAL OF LIPOSOME RESEARCH

Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

(2011) G. Francia et al.   MOLECULAR CANCER THERAPEUTICS

Metronomic gemcitabine suppresses tumour growth, improves perfusion and reduces hypoxia in human pancreatic ductal adenocarcinoma

(2010) K K Y Cham et al.   BRITISH JOURNAL OF CANCER

Strategies for Prolonged Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

(2010) Panos Fidias et al.   JOURNAL OF CLINICAL ONCOLOGY

Metronomic chemotherapy: new rationale for new directions

(2010) Eddy Pasquier et al.   Nature Reviews Clinical Oncology

Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension

(2009) Weijuan Yao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer

(2009) E. Briasoulis et al.   CLINICAL CANCER RESEARCH

Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)

(2009) J. Doloff et al.   CURRENT CANCER DRUG TARGETS